相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer
Saioa Mendaza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
SP1-Mediated Upregulation of lncRNA LINC01614 Functions a ceRNA for miR-383 to Facilitate Glioma Progression Through Regulation of ADAM 12
Hao Wang et al.
ONCOTARGETS AND THERAPY (2020)
Selective estrogen receptor modulators decrease invasiveness in pituitary adenoma cell lines AtT-20 and TtT/GF by affecting expression of MMP-14 and ADAM12
Zhuo Zhang et al.
FEBS OPEN BIO (2020)
Epigenetic Regulation of a Disintegrin and Metalloproteinase (ADAM) Transcription in Colorectal Cancer Cells: Involvement of β-Catenin, BRG1, and KDM4
Lina Sun et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Integrated bioinformatics analysis of key genes involved in progress of colon cancer
Haojie Yang et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
ADAM protein family - its role in tumorigenesis, mechanisms of chemo-resistance and potential as diagnostic and prognostic factors
L. Zadka et al.
NEOPLASMA (2018)
Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior?
Sara Crotti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
TLR4-mediated galectin-1 production triggers epithelial-mesenchymal transition in colon cancer cells through ADAM10-and ADAM17-associated lactate production
Ga Bin Park et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
The Epigenomics of Embryonic Pathway Signaling in Colorectal Cancer
Curt Balch et al.
FRONTIERS IN PHARMACOLOGY (2017)
ADAM Metalloprotease-Released Cancer Biomarkers
Peter Herrlich et al.
TRENDS IN CANCER (2017)
Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital
Bello Arkilla Magaji et al.
BMC CANCER (2017)
The ADAMs family of proteases as targets for the treatment of cancer
Maeve Mullooly et al.
CANCER BIOLOGY & THERAPY (2016)
Expression of ADAM12 is regulated by E2F1 in small cell lung cancer
Zunling Li et al.
ONCOLOGY REPORTS (2015)
ADAM-12 as a Diagnostic Marker for the Proliferation, Migration and Invasion in Patients with Small Cell Lung Cancer
Shuhong Shao et al.
PLOS ONE (2014)
Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma
Enping Xu et al.
CARCINOGENESIS (2013)
Alternative mRNA Splicing Generates Two Distinct ADAM12 Prodomain Variants
Sara Duhachek-Muggy et al.
PLOS ONE (2013)
Biomarkers in precision therapy in colorectal cancer
Marlies S. Reimers et al.
GASTROENTEROLOGY REPORT (2013)
The expression of ADAM23 and its correlation with promoter methylation in non-small-cell lung carcinoma
Chunyan Hu et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2011)
ADAM12 Transmembrane and Secreted Isoforms Promote Breast Tumor Growth A DISTINCT ROLE FOR ADAM12-S PROTEIN IN TUMOR METASTASIS
Roopali Roy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
ADAMs in cancer cell proliferation and progression
Satsuki Mochizuki et al.
CANCER SCIENCE (2007)
ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression
L. Peduto et al.
ONCOGENE (2006)
分享论文
